Marker Therapeutics, Inc. MRKR
1.09 USD -0.23 (-17.42%)
Regular-session close
1.01 -0.08 -7.17%
After hours · Nov 20, 7:55 PM ET
1.09 Day range 1.45
0.81 52-week range 2.46
- YTD
- -26.85%
- 1 year
- +10.10%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.55M | 6.59M | 3.31M | 3.51M | 1.24M | |
| 3.55M | 6.59M | 3.31M | 3.51M | 1.24M | |
| -12.89M | -11.12M | -14.58M | -19.79M | -39.48M | |
| -12.16M | -10.73M | -8.24M | -29.93M | -41.88M | |
| -0.79 | -1.19 | -0.94 | -3.58 | -5.47 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 17.04M | 19.19M | 15.11M | 11.78M | 43.50M | |
| 19.07M | 22.02M | 17.13M | 34.42M | 68.14M | |
| 2.27M | 3.46M | 3.07M | 14.82M | 24.15M | |
| 16.80M | 18.56M | 14.05M | 19.60M | 43.99M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.01M | -10.91M | -16.44M | -26.97M | -27.28M | |
| 9.86M | 14.99M | 1.11M | 202.13K | 52.56M | |
| -2.15M | 4.08M | 3.33M | -31.72M | 22.14M |
